COPANLISIB - INJECTION
PHONETIC PRONUNCIATION: (KOE-pan-LIS-ib)
COMMON BRAND NAME(S): Aliqopa
GENERIC NAME(S): copanlisib di-HCl
Uses
USES: This medication is used to treat a certain type of cancer (follicular lymphoma). It works by slowing or stopping the growth of cancer cells.
How to use COPANLISIB - INJECTION
HOW TO USE: Read the Patient Information Leaflet if available from your pharmacist before you start using copanlisib and each time you get a refill. If you have any questions, ask your doctor or pharmacist. This medication is given by injection into a vein over 1 hour as directed by your doctor. It is usually given once a week for 3 weeks followed by a 1-week rest period. The cycle is then repeated as directed by your doctor. The dosage is based on your medical condition, response to treatment, and other medications you may be taking. Be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products). Use this medication regularly to get the most benefit from it. To help you remember, mark the days on the calendar when you need to receive the medication. Avoid eating grapefruit or drinking grapefruit juice while using this medication unless your doctor or pharmacist says you may do so safely. Grapefruit can increase the chance of side effects with this medicine. Ask your doctor or pharmacist for more details.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for COPANLISIB - INJECTION
Copanlisib injection is used to treat adults with certain types of non-Hodgkin's lymphoma (NHL) that have not responded to other treatments or have relapsed.
Copanlisib is a kinase inhibitor that works by blocking the action of certain enzymes involved in the growth and survival of cancer cells, thereby inhibiting their proliferation.
Copanlisib injection is given as an infusion through a vein (intravenous infusion) by a healthcare professional in a hospital or clinic.
Common side effects of Copanlisib injection may include hyperglycemia (high blood sugar), hypertension (high blood pressure), diarrhea, nausea, fatigue, and respiratory tract infections.
Yes, serious side effects of Copanlisib injection may include severe infections, liver problems, lung problems, infusion-related reactions, and severe skin reactions. It is important to seek immediate medical attention if any of these occur.
Yes, Copanlisib injection may interact with other medications, including certain antibiotics, antifungal drugs, and medications that affect blood clotting. It is important to inform your healthcare provider about all the medications you are taking before starting Copanlisib injection.
No, Copanlisib injection is not recommended during pregnancy as it may harm the unborn baby. It is also not known if Copanlisib passes into breast milk, so breastfeeding should be avoided while receiving Copanlisib injection.
The dosing schedule for Copanlisib injection may vary depending on individual factors and the specific type of non-Hodgkin's lymphoma being treated. Your healthcare provider will determine the appropriate dosing regimen for you.
Copanlisib injection is not a cure for non-Hodgkin's lymphoma. It is used to control the disease and slow down its progression in patients who have not responded to other treatments or have relapsed.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet